National Health Investors (NYSE:NHI) Downgraded by Zacks Investment Research to “Sell” – MarketBeat

0
50

National Health Investors (NYSE:NHI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Wednesday, Zacks.com reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other equities analysts also recently commented on the stock. BMO Capital Markets downgraded shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 price objective for the company. in a research note on Thursday, January 7th. KeyCorp raised shares of National Health Investors from an “underweight” rating to a “sector weight” rating in a research note on Monday, December 14th. Berenberg Bank downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, December 2nd. Finally, Mizuho downgraded National Health Investors from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $56.00 to $55.00 in a research report on Wednesday, January 13th. Three equities research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. National Health Investors presently has a consensus rating of “Hold” and a consensus target price of $61.57.

(Ad)

With industry veterans on board and a unique strategy that could position the company to becoming the premium cannabis brand in Canada, this small-cap player looks on the verge of being discovered!

Shares of NHI stock opened at $67.80 on Wednesday. The firm has a market cap of $3.03 billion, a price-to-earnings ratio of 15.92 and a beta of 0.88. National Health Investors has a 52-week low of $31.37 and a 52-week high of $91.12. The company has a quick ratio of 13.13, a current ratio of 13.13 and a debt-to-equity ratio of 1.02. The company’s 50 day moving average is $67.49 and its 200 day moving average is $64.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Sunday, February 21st. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.19). The business had revenue of $81.24 million during the quarter, compared to the consensus estimate of $84.22 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The business’s quarterly revenue was down 1.2% on a year-over-year basis. During the same period last year, the firm earned $1.41 EPS. Analysts anticipate that National Health Investors will post 5.59 EPS for the current fiscal year.

In related news, Director Robert G. Adams acquired 2,000 shares of the company’s stock in a transaction dated Monday, December 14th. The shares were purchased at an average cost of $67.75 per share, with a total value of $135,500.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.74% of the stock is owned by insiders.

A number of large investors have recently bought and sold shares of NHI. Marshall Wace North America L.P. purchased a new stake in National Health Investors in the first quarter valued at $31,000. International Assets Investment Management LLC purchased a new stake in National Health Investors in the fourth quarter valued at $32,000. Van ECK Associates Corp boosted its holdings in National Health Investors by 23.5% in the third quarter. Van ECK Associates Corp now owns 1,298 shares of the real estate investment trust’s stock valued at $78,000 after purchasing an additional 247 shares during the last quarter. LeJeune Puetz Investment Counsel LLC purchased a new stake in National Health Investors in the fourth quarter valued at $183,000. Finally, Avantax Advisory Services Inc. purchased a new stake in National Health Investors in the third quarter valued at $202,000. 65.72% of the stock is currently owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: What is included in the gross domestic product?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

7 Stocks That Will Help You Forget About the Fed

Normally when the Federal Reserve (i.e. the Fed) makes an announcement, the market reacts predictably. That’s due, in large part, to the nature of what the Fed normally announces. Will interest rates go up, down, or remain unchanged? And for their part, the markets have a pretty good idea what the Fed will do before they do it.

But the Fed’s announcement of August 26 was a little different. They talked briefly about interest rates (they’re staying really low for a long time). But they were more concerned about inflation. Well, the Fed is always concerned about inflation, but this time they really mean it. Basic economics says that low-interest rates should spur inflation.

However, the market has been defying conventional wisdom and the Fed is not getting the inflation they want. So the Fed has basically said that they’re letting inflation go rogue. If it goes above their target 2% rate, so be it. The Fed is done trying to hit a target.
At first, the markets cheered the news. Not only was the Fed not taking away the punch bowl, but they were also going to keep the low rate liquidity going for a long time!

But after a little while to digest things, investors are realizing they have to be grown-ups about this. And now investors are considering how to rebalance their portfolios for the remainder of 2020.

I don’t know about them, but if I were you I would target companies that have a high free cash flow (FCF). Whether it’s your personal finances or in evaluating a stock, cash flow is your friend.

When a corporation has high FCF, they have more strong growth in good markets and more flexibility during when the economy is weaker.

As institutional investors come back into the market, it’s time for you to reposition your portfolio for whatever comes next.

View the “7 Stocks That Will Help You Forget About the Fed”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here